(Q45326635)

13 December 2017

title

Modeling population immunity to support efforts to end the transmission of live polioviruses (English)

1 reference

13 December 2017

2

Mark A Pallansch

1 reference

Radboud J Duintjer Tebbens

13 December 2017

series ordinal

3

object named as

Radboud J Duintjer Tebbens

1 reference

13 December 2017

5

Stephen L Cochi

1 reference

13 December 2017

4

Steve G Wassilak

1 reference

13 December 2017

1

Kimberly M Thompson

1 reference

13 December 2017

publication date

17 September 2012

1 reference

13 December 2017

1 reference

13 December 2017

volume

33

1 reference

13 December 2017

issue

4

1 reference

13 December 2017

page(s)

647-663

1 reference

Preeradication vaccine policy options for poliovirus infection and disease control.

13 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01891.X

Eradication versus control for poliomyelitis: an economic analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01891.X

From emergence to eradication: the epidemiology of poliomyelitis deconstructed

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01891.X

A dynamic model of poliomyelitis outbreaks: learning from the past to help inform the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01891.X

Strategic planning for measles control: using data to inform optimal vaccination strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01891.X

Modeling measles, mumps, and rubella: implications for the design of vaccination programs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01891.X

Scheduling of measles vaccination in low-income countries: projections of a dynamic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01891.X

Expert review on poliovirus immunity and transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01891.X

Review and assessment of poliovirus immunity and transmission: synthesis of knowledge gaps and identification of research needs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01891.X

The effect of ongoing exposure dynamics in dose response relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01891.X

A study of polio vaccination in infancy: excretion following challenge with live virus by children given killed or living poliovaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01891.X

Vaccine policy changes and epidemiology of poliomyelitis in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01891.X

Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01891.X

Seroprevalence of antibody against poliovirus in inner-city preschool children. Implications for vaccination policy in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01891.X

Intrafamilial and interfamilial spread of living vaccine strains of polioviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01891.X

VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION *

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01891.X

Search for poliovirus long-term excretors among patients affected by agammaglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01891.X

Persistence of vaccine-derived polioviruses among immunodeficient persons with vaccine-associated paralytic poliomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01891.X

Randomized, placebo-controlled trial of inactivated poliovirus vaccine in Cuba

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01891.X

Herd immunity: history, theory, practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01891.X

Effectiveness of immunization against paralytic poliomyelitis in Nigeria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01891.X

A statistical model of the international spread of wild poliovirus in Africa used to predict and prevent outbreaks

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01891.X

Current polio global eradication and control policy options: perspectives from modeling and prerequisites for oral poliovirus vaccine cessation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01891.X

Characterizing poliovirus transmission and evolution: insights from modeling experiences with wild and vaccine-related polioviruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01891.X

Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01891.X

Individual versus public priorities in the determination of optimal vaccination policies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01891.X

Retrospective cost-effectiveness analyses for polio vaccination in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01891.X

Polio outbreak in Tajikistan is cause for alarm

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01891.X

Yemen embarks on its seventh round of polio immunisations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01891.X

A large vaccine-derived poliovirus outbreak on Madura Island--Indonesia, 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01891.X

Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01891.X

Implications of a circulating vaccine-derived poliovirus in Nigeria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01891.X

Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01891.X

Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01891.X

Asymptomatic Wild‐Type Poliovirus Infection in India among Children with Previous Oral Poliovirus Vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2012.01891.X

Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review

21 January 2018

1 reference

12 December 2020

Mucosal Immunity Induced by Enhanced-Potency Inactivated and Oral Polio Vaccines

1 reference

12 December 2020

The efficacy of DPT and oral poliomyelitis immunization schedules initiated from birth to 12 weeks of age.

1 reference

12 December 2020

Studies of the immunogenicity, communicability and genetic stability of oral poliovaccine administered during the winter

1 reference

12 December 2020

Quantitative relationship of preexisting homotypic antibodies to the excretion of attenuated poliovirus type 1

1 reference

12 December 2020

Mucosal immune response to poliovirus vaccines in childhood

1 reference

12 December 2020

Some observations on poliomyelitis lameness surveys.

1 reference

12 December 2020

Lessons from Cuba: mass campaign administration of trivalent oral poliovirus vaccine and seroprevalence of poliovirus neutralizing antibodies.

1 reference

12 December 2020

Combined immunization of infants with oral and inactivated poliovirus vaccines: results of a randomized trial in The Gambia, Oman, and Thailand. WHO Collaborative Study Group on Oral and Inactivated Poliovirus Vaccines

1 reference

12 December 2020

Outbreak of paralytic poliomyelitis in Albania, 1996: high attack rate among adults and apparent interruption of transmission following nationwide mass vaccination

1 reference

12 December 2020

Search for poliovirus carriers among people with primary immune deficiency diseases in the United States, Mexico, Brazil, and the United Kingdom

1 reference

12 December 2020

Policy. OPV cessation--the final step to a "polio-free" world

1 reference

12 December 2020

Poliovirus vaccine shedding among persons with HIV in Abidjan, Cote d'Ivoire

1 reference

12 December 2020

Outbreak news. Poliomyelitis, Namibia

1 reference

12 December 2020

Global surveillance and the value of information: the case of the global polio laboratory network

1 reference

12 December 2020

The risks, costs, and benefits of possible future global policies for managing polioviruses

1 reference

12 December 2020

The case for cooperation in managing and maintaining the end of poliomyelitis: stockpile needs and coordinated OPV cessation.

1 reference

12 December 2020

Progress toward poliomyelitis eradication--Afghanistan and Pakistan, 2008

1 reference

12 December 2020

Polio vaccines and polio immunization in the pre-eradication era: WHO position paper

1 reference

12 December 2020

Outbreak news.Outbreak of poliomyelitis, Republic of the Congo, September 2010–February 2011

1 reference

12 December 2020

Trends in the risk of U.S. polio outbreaks and poliovirus vaccine availability for response

1 reference

12 December 2020

10.1111/J.1539-6924.2012.01891.X

Identifiers

DOI

1 reference

13 December 2017

0 references

1 reference